TSA demonstrated that the benefits of effective rate of syndrome, IL-4, and IFN-γ were conclusive, while the results of effective rate of colonoscopy and pathological examination were inconclusive and need to be confirmed by more studies. This evidence concerns the gene IL4 and Down syndrome.